| Balance Sheets | 2025-07-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 10,325 | |||
| Accounts receivable, net | 9,474 | |||
| Prepaid expenses and other current assets | 1,215 | |||
| Total current assets | 21,014 | |||
| Operating lease right-of-use assets, net | 4,771 | |||
| Property and equipment, net | 4,230 | |||
| Other long-term assets | 196 | |||
| Goodwill | 335 | |||
| Total assets | 30,546 | |||
| Accounts payable | 4,845 | |||
| Accrued liabilities | 1,801 | |||
| Current portion of operating lease liabilities | 1,506 | |||
| Other current liability | 116 | |||
| Deferred revenue | 14,430 | |||
| Total current liabilities | 22,698 | |||
| Non-current operating lease liabilities | 4,244 | |||
| Other non-current liabilities | 66 | |||
| Total liabilities | 27,008 | |||
| Common stock, .001 par value 200,000,000 shares authorized 13,908,754 and 13,897,503 shares issued and 13,788,421 and 13,777,170 outstanding as of july 31, 2025 and april 30, 2025, respectively | 14 | |||
| Treasury stock, at cost | 708 | |||
| Additional paid-in capital | 84,560 | |||
| Accumulated deficit | -80,358 | |||
| Total stockholders equity attributable to champions oncology, inc | 3,508 | |||
| Noncontrolling interest | 30 | |||
| Total stockholders' equity | 3,538 | |||
| Total liabilities and stockholders equity | 30,546 | |||
CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR)